OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 128 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $179,000 | -83.9% | 525 | -86.8% | 0.01% | -79.2% |
| Q4 2015 | $1,114,000 | -8.3% | 3,966 | -17.3% | 0.02% | -17.2% |
| Q3 2015 | $1,215,000 | +192.1% | 4,794 | -3.3% | 0.03% | +222.2% |
| Q2 2015 | $416,000 | +123.7% | 4,956 | -14.8% | 0.01% | +200.0% |
| Q1 2015 | $186,000 | -50.0% | 5,815 | -56.1% | 0.00% | -57.1% |
| Q4 2014 | $372,000 | -60.7% | 13,247 | -84.3% | 0.01% | -65.0% |
| Q3 2014 | $946,000 | +1450.8% | 84,219 | +5140.8% | 0.02% | +1900.0% |
| Q2 2014 | $61,000 | +238.9% | 1,607 | +318.5% | 0.00% | – |
| Q1 2014 | $18,000 | – | 384 | +1820.0% | 0.00% | – |
| Q4 2013 | $0 | -100.0% | 20 | -99.9% | 0.00% | -100.0% |
| Q3 2013 | $181,000 | -10.0% | 26,720 | -0.7% | 0.00% | -20.0% |
| Q2 2013 | $201,000 | – | 26,920 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 5,427,559 | $2,334,000 | 1.60% |
| Scale Management, LLC | 1,312,575 | $564,000 | 1.34% |
| Foresite Capital Management III, LLC | 2,542,575 | $1,093,000 | 0.75% |
| BVF INC/IL | 5,252,100 | $2,258,000 | 0.48% |
| TIVERTON ASSET MANAGEMENT LLC | 45,313 | $4,261,000 | 0.18% |
| Baupost Group | 22,268,399 | $9,575,000 | 0.13% |
| Rhenman & Partners Asset Management AB | 1,200,000 | $516,000 | 0.09% |
| NEA Management Company, LLC | 370,900 | $1,595,000 | 0.08% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $2,649,000 | 0.06% |
| Palo Alto Investors LP | 1,673,024 | $719,000 | 0.05% |